Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2025-11-27 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement regarding a specific product development (approval of Vitamin A Palmitate). It does not fit into financial reporting, governance, or specific corporate action categories like dividends or share buybacks. As it is a general regulatory announcement regarding business operations that does not fall into a more specific category, it is classified as a Regulatory Filing (RNS).
2025-11-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It explicitly details the repurchase of 2,000,000 shares by SSY Group Limited on 25 November 2025. According to the filing definitions, reports of a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-11-25 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement issued by SSY Group Limited regarding the approval of drug production and registration for several products from the NMPA. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general regulatory announcement regarding business developments that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-11-24 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from SSY Group Limited regarding the approval of a new drug (Indobufen Tablets) by the National Medical Products Administration. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate update regarding business development that does not fall into the other specialized categories, it is classified as a general regulatory filing.
2025-11-14 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 85% confidence The document is a voluntary announcement by a Hong Kong listed company about product development approval (generic drug consistency evaluation) rather than financial results, dividends, management changes, or any specific report. It does not fit any specialized category like earnings release, ESG report, or M&A. It is a general corporate regulatory announcement, making it a fallback 'Regulatory Filings' (RNS).
2025-11-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 80% confidence The document is a Form FF301 monthly return under HKEX Listing Rules detailing movements in share capital, issued shares, treasury shares, share options, and repurchase transactions. It is a routine regulatory compliance filing rather than an Annual or Interim Report, Earnings Release, Share Issue announcement, or standalone buyback notice. There is no specific category for monthly return filings in the taxonomy, so it falls under the fallback “Regulatory Filings” category.
2025-11-03 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.